Resorcinol

Resorcinol

SCHEMBL1236660

Oc1cccc(O)c1.[Fe]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resorcinol SCHEMBL326229 0.96 CA12 (1.00) —
Resorcinol SCHEMBL15515 0.96 — —
Resorcinol SCHEMBL8517218 0.92 CA12 (0.92) —
Resorcinol SCHEMBL6842721 0.92 — —
Resorcinol SCHEMBL8442393 0.92 — —
Resorcinol SCHEMBL464804 0.92 — —
Resorcinol SCHEMBL7945602 0.92 — —
Resorcinol SCHEMBL11880713 0.92 — —
Resorcinol SCHEMBL20577903 0.92 — —
Resorcinol SCHEMBL3984288 0.92 CA12 (0.92) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005075379-A2 ROBUST CARBON MONOLITH HAVING HIERARCHICAL POROSITY UT-BATTELLE, LLC. (US) 2005-08-18 — — WO claimed
CN-103308368-A Biological sample processing composition and method VENTANA MED SYST INC 2013-09-18 — — CN disclosed
CN-101371125-B Biological sample treatment compositions and methods VENTANA MED SYST INC 2013-05-29 — — CN disclosed
US-20130129920-A1 ROBUST CARBON MONOLITH HAVING HIERARCHICAL POROSITY UNIVERSITY OF TENNESSE RESEARCH FOUNDATION (US) 2013-05-23 — — US disclosed
US-8366979-B2 Robust carbon monolith having hierarchical porosity UT-BATTELLE, LLC (US) 2013-02-05 — — US disclosed
EP-2469263-A1 Biological sample processing composition and method Ventana Medical Systems, Inc. (US) 2012-06-27 — — EP disclosed
US-20110140296-A1 ROBUST CARBON MONOLITH HAVING HIERARCHICAL POROSITY UT-BATTELLE, LLC (US) 2011-06-16 — — US disclosed
US-7892516-B2 Robust carbon monolith having hierarchical porosity UT-BATTELLE, LLC (US) 2011-02-22 — — US disclosed
US-20090044606-A1 Robust Carbon Monolith Having Hierarchical Porosity UT-BATTELLE, LLC (US) 2009-02-19 — — US disclosed
CN-101371125-A Biological sample treatment compositions and methods VENTANA MED SYST INC (US) 2009-02-18 — — CN disclosed
US-7449165-B2 Robust carbon monolith having hierarchical porosity UT-BATTELLE, LLC (US) 2008-11-11 — — US disclosed
EP-1977214-A2 BIOLOGICAL SAMPLE PROCESSING COMPOSITION AND METHOD Ventana Medical Systems, Inc. (US) 2008-10-08 — — EP disclosed
WO-2007084429-A2 BIOLOGICAL SAMPLE PROCESSING COMPOSITION AND METHOD VENTANA MEDICAL SYSTEMS, INC. (US) 2007-07-26 — — WO disclosed
US-20070172911-A1 Biological sample processing composition and method VENTANA MEDICAL SYSTEMS, INC. 2007-07-26 — — US disclosed
WO-2005075379-A2 ROBUST CARBON MONOLITH HAVING HIERARCHICAL POROSITY UT-BATTELLE, LLC. (US) 2005-08-18 — — WO disclosed
US-20050169829-A1 Robust carbon monolith having hierarchical porosity ENERGY, U.S. DEPARTMENT OF 2005-08-04 — — US disclosed
EP-1366196-A4 METHODS AND COMPOSITIONS OF AMPLIFYING RNA BAYLOR COLLEGE MEDICINE (US) 2004-07-07 — — EP disclosed
EP-1366196-A2 METHODS AND COMPOSITIONS OF AMPLIFYING RNA BAYLOR COLLEGE OF MEDICINE (US) 2003-12-03 — — EP disclosed
WO-2002065093-A2 METHODS AND COMPOSITIONS OF AMPLIFYING RNA BAYLOR COLLEGE OF MEDICINE (US) 2002-08-22 — — WO disclosed
Send feedback